Regenerative Medicine & Rehabilitation Challenges, Searches or Forum Topics - MedTech I.Q.2024-03-29T11:30:52Zhttp://medtechiq.ning.com/group/tissueengineeringregenerativemedicine/forum?groupUrl=tissueengineeringregenerativemedicine&feed=yes&xn_auth=noGraduate Student Designs Cheap, Portable Wound-Healing Devicetag:medtechiq.ning.com,2010-03-23:2140535:Topic:295752010-03-23T10:26:45.858ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br></br><br></br>As reported in MIT Tech Review ... <br></br><br></br><div><p>In mid-February ... after a massive earthquake leveled much of Port-au-Prince, Haiti, a wound-care team from Brigham and Women's hospital in Boston traveled to the devastated capital...</p>
<p><br></br></p>
<p>... The team's task was to help care for scores of patients suffering from the large open wounds that accompany amputations, crushed limbs, and other injuries. Among the team was MIT graduate student…</p>
</div>
Colleagues,<br/><br/>As reported in MIT Tech Review ... <br/><br/><div><p>In mid-February ... after a massive earthquake leveled much of Port-au-Prince, Haiti, a wound-care team from Brigham and Women's hospital in Boston traveled to the devastated capital...</p>
<p><br/></p>
<p>... The team's task was to help care for scores of patients suffering from the large open wounds that accompany amputations, crushed limbs, and other injuries. Among the team was MIT graduate student <a href="http://web.mit.edu/drz/www/" target="_blank">Danielle Zurovcik</a>, who had developed a cheap and portable version of the negative-pressure devices currently used to speed wound healing in hospitals...<br/></p>
<br/>
<table style="width: 302px; height: 536px;" class="ArticleImageTable" border="0" cellspacing="0">
<tbody><tr><td class="ArticleImageCell"><img style="width: 267px; height: 343px;" class="ArticleImage" src="http://www.technologyreview.com/files/38455/wound_x220.jpg" border="0"/></td>
</tr>
<tr><td class="ArticleCommentsCell"><b><br/>Pumping wounds:</b> Researchers hope that a simple bellows pump attached to a tube that’s applied to a wound dressing can generate enough negative pressure to spur healing. <br/> Credit: Danielle R. Zurovcik<br/><br/></td>
</tr>
</tbody>
</table>
<p><br/>... Negative-pressure therapy decreases the need to change wound dressings from one to three times per day to once every few days ... provide a way to improve care for patients after the emergency phase of relief efforts ... says <a href="http://www.cimit.org/bios/olson.html" target="_blank">Kristian Olson</a>, a physician at Massachusetts General Hospital, in Boston (and, a <span style="font-weight: bold;">leading Member of CIMIT -</span> a Triple Helix consortia clinicians, scientists & engineers), "Not only do I see it answering this need in developing countries, I think it could really enhance home therapy for chronic wounds in the U.S."</p>
<p><br/></p>
<p>... A number of commercial versions are available in the U.S. and are used to treat burns and chronic wounds such as bed sores or diabetic foot ulcers ... Existing devices are often heavy, about five to 10 pounds, and require an energy source to create the vacuum, making them difficult to apply in disaster settings... <br/></p>
<br/>... Zurovcik, inspired by a burn surgeon's plea, went a step further, designing a human-powered device that applies pressure via a simple
bellows pump weighing less than half a pound ... cut the pump's power requirements ... and, costs about $3 ... <br/><br/><br/>Read on at: <a href="http://www.technologyreview.com/biomedicine/24837/page2/">http://www.technologyreview.com/biomedicine/24837/page2/</a><br/><br/>ENJOY!<br/><br/>CC<br/></div> Regenerative Tissue Firm Founded by Dr. Anthony Atala ... Tengion files for $40M IPOtag:medtechiq.ning.com,2010-03-22:2140535:Topic:295682010-03-22T00:33:56.681ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br></br><br></br>As reported in Tech Journal South ... <a href="http://www.tengion.com/" target="_blank">Tengion</a>, a
company that creates working organs using a patient’s own cells, plans to raise $40 million in an initial public offering of stock. Tengion has a research laboratory and pilot facility in Winston Salem, NC, where co-scientific founder Dr. Anthony Atala heads the Wake Forest Institute for Regenerative Medicine...<br></br><br></br>See clip from MedTech-IQ Videolibrary on Dr Atala:…
Colleagues,<br/><br/>As reported in Tech Journal South ... <a href="http://www.tengion.com/" target="_blank">Tengion</a>, a
company that creates working organs using a patient’s own cells, plans to raise $40 million in an initial public offering of stock. Tengion has a research laboratory and pilot facility in Winston Salem, NC, where co-scientific founder Dr. Anthony Atala heads the Wake Forest Institute for Regenerative Medicine...<br/><br/>See clip from MedTech-IQ Videolibrary on Dr Atala: <a href="http://medtechiq.ning.com/video/2140535:Video:1662" class="title">Regenerative Medicine: Dr Anthony Atala, MD, Wake Forest
describes progress in organ replacement research</a> ...<br/><br/>...The company’s patented integrated technology platform was developed
over the past two decades by scientists at Children’s Hospital Boston (a teaching affiliate of Harvard Medical School), MIT, and the Wake Forest Institute for Regenerative Medicine ...<br/><br/>...Founded in 2003, the company has no revenue ... But, the company owns or licenses over 30 US patents and patent applications
and over 100 international patents and filings related to its platform and nine product candidates...<br/><br/>... Dr. Atala and his lab have created working human bladders on cell
scaffolds, a unique sort of construction work. Part of his research is funded by the U.S. <span style="font-weight: bold;">Armed Forces Institute of Regenerative Medicine (AFIRM)</span> ... <br/><br/>...Tengion’s corporate headquarters and commercial manufacturing
facility are in East Norriton, Pennsylvania. The company has research offices, a development laboratory and a pilot manufacturing facility in Winston Salem, North Carolina.<br/><br/>Read on at: <a href="http://www.techjournalsouth.com/2010/03/regenerative-tissue-firm-tengion-files-for-40m-ipo/">http://www.techjournalsouth.com/2010/03/regenerative-tissue-firm-tengion-files-for-40m-ipo/</a><br/><br/>ENJOY!<br/><br/>CC<br/> New surgical bone screw biodegrades in two yearstag:medtechiq.ning.com,2010-03-03:2140535:Topic:292422010-03-03T22:33:30.528ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br></br><br></br>As reported in CNET Health Tech ... <br></br><br></br><p style="text-align: left;"><img alt="" src="http://storage.ning.com/topology/rest/1.0/file/get/2310101865?profile=original"></img></p>
<br></br><p>This month, researchers at the <a href="http://www.ifam.fraunhofer.de/index.php?seite=&lang=en">Fraunhofer Institute for Manufacturing Engineering and Applied Materials Research</a> (IFAM) in Bremen, Germany, are <a href="http://www.fraunhofer.de/en/press/research-news/2010/03/bone-hard-bimaterial.jsp">unveiling
a new type of screw</a> that not only biodegrades within two…</p>
Colleagues,<br/><br/>As reported in CNET Health Tech ... <br/><br/><p style="text-align: left;"><img src="http://storage.ning.com/topology/rest/1.0/file/get/2310101865?profile=original" alt=""/></p>
<br/><p>This month, researchers at the <a href="http://www.ifam.fraunhofer.de/index.php?seite=&lang=en">Fraunhofer Institute for Manufacturing Engineering and Applied Materials Research</a>
(IFAM) in Bremen, Germany, are <a href="http://www.fraunhofer.de/en/press/research-news/2010/03/bone-hard-bimaterial.jsp">unveiling<br />
a new type of screw</a> that not only biodegrades within two years but<br />
actually encourages bone growth into the implant itself so as not to<br />
leave gaping holes where the screws used to be... </p>
<p><br/></p>
<p>... Current biodegradable screws are made of <a href="http://en.wikipedia.org/wiki/Polylactic_acid">polylactic acid</a>, but those leave holes once they degrade. IFAM researchers developed a
moldable composite made of polylactic acid and <a href="http://en.wikipedia.org/wiki/Hydroxylapatite">hydroxylapatite</a>,<br />
a ceramic that <a href="http://www.ifam.fraunhofer.de/index.php?seite=/2801/biomat/&lang=en">Philipp<br />
Imgrund</a> of IFAM's biomaterial technology department says is the<br />
main constituent of bone material...</p>
<p><br/></p>
<p>... IFAM engineers rely on conventional injection-molding methods, but they developed a granulate from the biomaterials with a net shape that
results in a robust screw. The prototype's properties are very similar<br />
to a real bone's, with compressive strength of more than 130 newtons per<br />
square millimeter (a real bone withstands 130 to 180)...</p>
<p><br/></p>
<p>Read on at: <a href="http://news.cnet.com/8301-27083_3-10461572-247.html">http://news.cnet.com/8301-27083_3-10461572-247.html</a></p>
<p><br/></p>
<p>ENJOY!</p>
<p><br/></p>
<p>CC<br/></p> Orthopedic Biomaterials Market in the U.S. to Reach Almost $6.3 Billion by 2016tag:medtechiq.ning.com,2010-02-17:2140535:Topic:288532010-02-17T22:42:04.451ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br></br><br></br>According to a new global report series by iData Research (<a href="http://www.idataresearch.net/" target="_blank">www.idataresearch.net</a>),
the leading authority in medical device, dental and pharmaceutical<br></br>
market research, the U.S. market for orthopedic biomaterials grew by<br></br>
11.5% in 2009 and is estimated to reach almost <span class="xn-money">$6.3 billion</span><br></br>
by 2016 ...<br></br><br></br>... The report states
that the launch of single-injection-products will…
Colleagues,<br/><br/>According to a new global report series by iData Research (<a target="_blank" href="http://www.idataresearch.net/">www.idataresearch.net</a>),
the leading authority in medical device, dental and pharmaceutical<br/>
market research, the U.S. market for orthopedic biomaterials grew by<br/>
11.5% in 2009 and is estimated to reach almost <span class="xn-money">$6.3 billion</span><br/>
by 2016 ...<br/><br/>... The report states
that the launch of single-injection-products will stimulate market growth ... while the aging population and increased incidence of osteoarthritis will drive the overall market for orthopedic biomaterials...<br/><br/>...Orthopedic
biomaterials are implanted or applied in or near bone to facilitate<br/>
healing. This procedure fills in areas where bone tissue is depleted to<br/>
restore structure and allow for repair, leading to bone augmentation.<br/>
Some of the fastest-growing market segments include orthopedic stem<br/>
cells and cartilage repair...<br/>
<br/><p>The report also ... includes comprehensive analyses of the markets for:</p>
<br/><pre> Growth Factor Therapy<br/> Bone Graft Substitutes<br/> Machined Bone Allografts<br/> Hyaluronic Acid Viscosupplementation<br/> Resorbable Tissue and Bone Fixation Devices<br/> Tendon Allografts<br/> Cartilage Repair<br/> Platelet and Bone Marrow Concentration<br/> Stem Cell Therapy<br/></pre>
Read on at: <a target="_blank" href="http://www.idataresearch.net/idata/registration.php">http://www.idataresearch.net/idata/registration.php</a><br />
<p><br/></p>
<p>ENJOY!</p>
<p><br/></p>
<p>CC<br/></p>
<p><a target="_blank" href="http://www.idataresearch.net/idata/registration.php"><br/></a></p>
<br/> Regenerative Medicine ... No Longer Futuristictag:medtechiq.ning.com,2009-12-15:2140535:Topic:277412009-12-15T09:45:47.420ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br />
<br />
... “Regenerative medicine; it’s not futuristic medicine anymore,” said Dr. Alan Russell, founding director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh...<br />
<br />
... Russell shared his overview of regenerative medicine during the State of Science Workshop, ... at Walter Reed Army Medical Center ... The concept of regenerative medicine is to replace or regenerate human cells, tissues or organs to restore or establish normal function, according to the…
Colleagues,<br />
<br />
... “Regenerative medicine; it’s not futuristic medicine anymore,” said Dr. Alan Russell, founding director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh...<br />
<br />
... Russell shared his overview of regenerative medicine during the State of Science Workshop, ... at Walter Reed Army Medical Center ... The concept of regenerative medicine is to replace or regenerate human cells, tissues or organs to restore or establish normal function, according to the Armed Forces Institute of Regenerative Medicine (AFIRM), established by the U.S. Department of Defense to develop new products and therapies to treat severe injuries suffered by U.S. service members in current wars...<br />
<br />
... Current AFIRM projects include the development of engineered human ear and nose replacements, along with a skin substitute to improve recovery from large area burns. The first clinical trials using technology for the ear could start in about a year, according to Col. Robert Vandre, project director for AFIRM...<br />
<br />
... Vandre said two patients involved in studies at the U.S. Army Institute of Surgical Research located at Brooke Army Medical Center at Fort Sam Houston, Texas, were able to regenerate and grow missing muscle using a surgical implantation of extracellular matrix (ECM), a biologic agent devoid of cells used as a structure for tissue to grow within...<br />
<br />
Read on at: <a href="http://www.health.mil/Press/Release.aspx?ID=1038" target="_blank">http://www.health.mil/Press/Release.aspx?ID=1038</a><br />
<br />
To see MedTech-IQ video on "Regenerative" medicine see: <a href="http://medtechiq.ning.com/video/video/search?q=regenerative">http://medtechiq.ning.com/video/video/search?q=regenerative</a><br />
<br />
ENJOY!<br />
<br />
CC Robo-Rehab at Hometag:medtechiq.ning.com,2009-11-13:2140535:Topic:264012009-11-13T12:21:51.511ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues.<br />
<br />
As reported in MIT Tech Review ... When a person suffers a stroke, the interruption of blood flow to the brain can cause lasting loss of function in the limbs. Persistent physical therapy can improve motor control by strengthening connections between the limb and brain. Now, a group at Northeastern University has developed several portable robotic devices that may aid in the rehabilitation process; unlike other rehabilitation devices, these may also let patients continue therapy at…
Colleagues.<br />
<br />
As reported in MIT Tech Review ... When a person suffers a stroke, the interruption of blood flow to the brain can cause lasting loss of function in the limbs. Persistent physical therapy can improve motor control by strengthening connections between the limb and brain. Now, a group at Northeastern University has developed several portable robotic devices that may aid in the rehabilitation process; unlike other rehabilitation devices, these may also let patients continue therapy at home.<br />
<br />
... Stroke is the leading cause of disability in the United States; over two-thirds of stroke survivors are left with a disability, according to the National Stroke Association. Repetitive physical therapy that applies force to an affected limb can encourage motor signals to reach the brain and build new pathways of control. These exercises can help not just people recovering from a stroke, but also those suffering from other conditions, such as cerebral palsy or degenerative muscle diseases...<br />
<br />
... Several rehabilitation devices currently in use, such as Rocomo's Lokomat machine or the University of Twente's Lopes, were designed to help people walk better--but these systems tend to be bulky and expensive...<br />
<br />
... The Northeastern researchers have developed devices for the knee, wrist, pelvis, and ankle that they say are portable and cheap enough to be rented by small rehabilitation or medical centers, and potentially even individual patients. The team kept the devices small by using a substance called electro-rheological fluid, which becomes stickier when an electric current is applied, thus creating a stronger resistive force in the device. The fluid contains particles that form chains when electricity is applied, turning the liquid into more of a gel in a few milliseconds...<br />
<br />
Read on at: <a href="http://www.technologyreview.com/computing/23939/?nlid=2512&a=f">http://www.technologyreview.com/computing/23939/?nlid=2512&a=f</a> 13 August 2009 DEADLINE for $112m DoD Orthopaedic Research Funding Opportunitiestag:medtechiq.ning.com,2009-07-25:2140535:Topic:219052009-07-25T21:00:29.792ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br />
<br />
Thanx are due, as is frequently the case, to the highly informed MedTech-IQ Member, Eric Noji, for this reminder ...<br />
<br />
The <b>Peer Reviewed Orthopaedic Research Program (PRORP)</b> was established by the U.S. Department of Defense (DOD) in Fiscal Year 2009 (FY09) to address the leading burden of injury and loss of fitness for military duty by funding innovative, high-impact, clinically relevant research to advance treatment and rapid rehabilitation from musculoskeletal injuries…
Colleagues,<br />
<br />
Thanx are due, as is frequently the case, to the highly informed MedTech-IQ Member, Eric Noji, for this reminder ...<br />
<br />
The <b>Peer Reviewed Orthopaedic Research Program (PRORP)</b> was established by the U.S. Department of Defense (DOD) in Fiscal Year 2009 (FY09) to address the leading burden of injury and loss of fitness for military duty by funding innovative, high-impact, clinically relevant research to advance treatment and rapid rehabilitation from musculoskeletal injuries sustained during combat or combat related activities. The FY09 PRORP provides a total appropriation of $112M to support military-relevant, peer-reviewed orthopaedic research...<br />
<br />
... The program highly encourages the submission of applications involving multidisciplinary collaborations among academia, industry, the military services, the Department of Veterans Affairs (VA), and other Federal Government agencies...<br />
<br />
The program is broken down into 5 separately managed funding opportunities:<br />
<br />
1. <b><u>Clinical Trial Award</u></b>; Grants.gov Funding Opportunity Number: W81XWH-09-PRORP-CTA<br />
* Independent investigators at or above the level of Assistant Professor (or equivalent)<br />
* Preproposal is required; application submission is by invitation only<br />
* Applications must address at least one of the following research focus areas:<br />
- enhancement of the tissue environment for healing;<br />
- prevention of complications;<br />
- restoration of joint function;<br />
- and treatment of orthopaedic injuries (and sequelae) of the spine not related to spinal cord injury<br />
* Maximum funding of $2.725M; Period of performance not to exceed 4 years<br />
* Pre-application (Preproposal): August 13, 2009, 5:00 p.m. Eastern Time<br />
* Application: November 17, 2009, 11:59 p.m. Eastern Time<br />
<br />
2. <b><u>Hypothesis Development Award</u></b>;Grants.gov Funding Opportunity Number:W81XWH-09-PRORP-HDA<br />
* Investigators at all academic levels (or equivalent)<br />
* Letter of intent is required<br />
* Funds the initial exploration of innovative, untested, potentially groundbreaking concepts in all areas of orthopaedic research relevant to treatment and rehabilitation from military combat-related injuries<br />
* Maximum funding of $100K; Period of performance not to exceed 18 months<br />
* Pre-application (Letter of Intent): August 25, 2009, 5:00 p.m. Eastern Time<br />
* Application: September 15, 2009, 11:59 p.m. Eastern Time<br />
<br />
3. <b><u>Idea Development Award</u></b>;Grants.gov Funding Opportunity Number:<br />
W81XWH-09-PRORP-IDA<br />
* Investigators at all academic levels (or equivalent)<br />
* Preproposal is required; application submission is by invitation only<br />
* Supports conceptually innovative, high-impact research from all areas of basic, translational, and clinical research as they relate to the research focus areas:<br />
- enhancement of the tissue environment for healing;<br />
- prevention of complications;<br />
- maintenance/enhancement of long-term socket performance/fit;<br />
- solution of critical issues in osseointegration<br />
* Maximum funding of $400K; Period of performance not to exceed 3 years<br />
* Pre-application (Preproposal): August 13, 2009, 5:00 p.m. Eastern Time<br />
* Application: November 17, 2009; 11:59 p.m. Eastern Time<br />
<br />
4. <b><u>Technology Development Award</u></b>; Grants.gov Funding Opportunity Number:<br />
W81XWH-09-PRORP-TDA<br />
* Independent investigators at all academic levels (or equivalent)<br />
* Preproposal is required; application submission is by invitation only<br />
* Provides funding for improved technologies and resources to advance the field of research focused on military combat-relevant orthopaedic injury and rehabilitative medicine. Applications must address at least one of the following research focus areas:<br />
- development of in vivo translational models for the acute injury environment and for restoration of joint function;<br />
- maintenance/ enhancement of long-term socket performance/fit<br />
* Maximum funding of $2M; Period of performance not to exceed 4 years<br />
* Pre-application (Preproposal): August 13, 2009, 5:00 p.m. Eastern Time<br />
* Application: November 17, 2009, 11:59 p.m. Eastern Time<br />
<br />
5. <b><u>Translational Research Partnership Award</u></b>; Grants.gov Funding Opportunity Number: W81XWH-09-PRORP-TRPA<br />
* Independent investigators at all academic levels (or equivalent)<br />
* Preproposal is required; application submission is by invitation only<br />
* Supports the development of multi-institutional, multidisciplinary translational research partnerships between clinicians and laboratory scientists to accelerate the movement of promising research hypotheses into clinical applications in a manner that would be less readily achievable through separate efforts. Applications must address at least one of the following research focus areas:<br />
- restoration of joint function;<br />
- orthopaedic injuries (and sequelae) of the spine not related to spinal cord injury;<br />
- acceleration of healing;<br />
- development of a functional innervated muscle for repair of soft tissue injury;<br />
- solution of critical issues in osseointegration<br />
* Maximum funding of $750K; Period of performance not to exceed 3 years<br />
* Pre-application (Preproposal): August 13, 2009, 5:00 p.m. Eastern Time<br />
* Application: November 17, 2009, 11:59 p.m. Eastern Time<br />
<br />
Read on at: <a href="http://cdmrp.army.mil/funding/prorp.htm">http://cdmrp.army.mil/funding/prorp.htm</a><br />
<br />
ENJOY!<br />
<br />
CC Artificial Knees Made to Order ... Knee Implant Firm ConforMIS Lands $50M Investmenttag:medtechiq.ning.com,2009-07-14:2140535:Topic:212692009-07-14T02:54:29.349ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br />
<br />
As reported in The Journal of New England Technology and MIT Tech Review ... medical device firm ConforMIS Inc. has raised $50 million from private equity and sovereign wealth funds in the U.S., Europe, Asia and the Middle East...<br />
<br />
... ConforMIS is taking a customized approach to knee replacement surgery, creating knee implants on demand that exactly match a patient's anatomy by bringing the technology of rapid prototyping, which converts a three-dimensional computer design into a…
Colleagues,<br />
<br />
As reported in The Journal of New England Technology and MIT Tech Review ... medical device firm ConforMIS Inc. has raised $50 million from private equity and sovereign wealth funds in the U.S., Europe, Asia and the Middle East...<br />
<br />
... ConforMIS is taking a customized approach to knee replacement surgery, creating knee implants on demand that exactly match a patient's anatomy by bringing the technology of rapid prototyping, which converts a three-dimensional computer design into a physical object, into the field of orthopedics. The company believes that such custom-made implants can make knee replacement surgery faster, more accurate, and less traumatic to the patient...<br />
<br />
... Typically, a surgeon chooses an artificial joint from several options of different sizes. ConforMIS, however, creates a custom implant based on imaging data of a patient's knee joint, a technology that the company calls iFit. ConforMIS transforms images from CT or MRI scans into a three-dimensional computer model using computer-aided design (CAD) software, which serves as a template for manufacturing the implant...<br />
<br />
Read on at: <a href="http://www.technologyreview.com/biomedicine/22988/?nlid=2170">http://www.technologyreview.com/biomedicine/22988/?nlid=2170</a><br />
<br />
ENJOY!<br />
<br />
CC Regenerative Medicine Group Launches in Washington, D.C.tag:medtechiq.ning.com,2009-07-07:2140535:Topic:210172009-07-07T17:54:00.980ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br />
<br />
As reported in Washington Business Journal ... Universities, life sciences companies, health care investors and patient advocates have banded together to inform policy makers, the media and the public about regenerative medicine.<br />
<br />
The D.C.-based <b>Alliance for Regenerative Medicine</b> aims to advance scientific research in regenerative medicine, which includes such methods as using stem cells to grow cells.<br />
<br />
The Alliance, which includes 13 charter members, is being co-operated by…
Colleagues,<br />
<br />
As reported in Washington Business Journal ... Universities, life sciences companies, health care investors and patient advocates have banded together to inform policy makers, the media and the public about regenerative medicine.<br />
<br />
The D.C.-based <b>Alliance for Regenerative Medicine</b> aims to advance scientific research in regenerative medicine, which includes such methods as using stem cells to grow cells.<br />
<br />
The Alliance, which includes 13 charter members, is being co-operated by H&K and Adjuvant Global Advisors ... Some of the initial charter members include the Wake Forest Institute for Regenerative Medicine, Stanford University, University of washington, Georgia Tech, Geron, Johnson & Johnson, and Aldagen. Investor organizations include Kleiner, Perkins and Proteus Ventures....<br />
<br />
Read on at: <a href="http://washington.bizjournals.com/washington/stories/2009/06/29/daily66.html?ed=2009-07-02&ana=e_du_pub">http://washington.bizjournals.com/washington/stories/2009/06/29/daily66.html?ed=2009-07-02&ana=e_du_pub</a><br />
<br />
ENJOY!<br />
<br />
CC NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative Host NanoWeek 2009tag:medtechiq.ning.com,2009-04-03:2140535:Topic:148362009-04-03T15:20:26.242ZCC-Conrad Clyburn-MedForeSighthttp://medtechiq.ning.com/profile/CCatMedTechIQ
Colleagues,<br />
<br />
The NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative will host NanoWeek 2009 from Tuesday, April 7 through Friday, April 10 at the Natcher Conference Center on the NIH campus in Bethesda, Md. NIH’s first-of-a-kind series of events focusing on science at the nanoscale, NanoWeek 2009 will include symposia with experts in the field, demonstrations, talks, and posters from NIH scientists.<br />
<br />
NanoWeek 2009’s first day will include seminars explaining the basic…
Colleagues,<br />
<br />
The NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative will host NanoWeek 2009 from Tuesday, April 7 through Friday, April 10 at the Natcher Conference Center on the NIH campus in Bethesda, Md. NIH’s first-of-a-kind series of events focusing on science at the nanoscale, NanoWeek 2009 will include symposia with experts in the field, demonstrations, talks, and posters from NIH scientists.<br />
<br />
NanoWeek 2009’s first day will include seminars explaining the basic concepts of nanotechnology, followed by summaries of current research being conducted and medical applications of nanotechnology. Speakers include:<br />
<br />
* Dr. Michael Gottesman, deputy director of Intramural Research at the National Institutes of Health<br />
* Dr. Richard Fisher, associate director for Science Policy and Legislation at the National Eye Institute<br />
* Dr. Catherine Lewis, director, Division of Cell Biology and Biophysics at the National Institute of General Medical Sciences<br />
* Dr. Piotr Grodzinski, director of the Nanotechnology in Cancer Program at the National Cancer Institute,<br />
* Dr. Karen Peterson, senior advisor to the Director of the National Institute of Biomedical Imaging and Bioengineering will also provide remarks.<br />
<br />
On Wednesday, NIH scientists will discuss ongoing nanotechnology research being performed at the NIH, along with more than 30 posters presenting work from NIH’s labs. There will be afternoon tours of nanotechnology labs at the National Heart, Lung, and Blood Institute, the National Cancer Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Biomedical Imaging and Bioengineering, and the National Institute of Neurological Disorders and Stroke.<br />
<br />
In coordination with IEEE, a leading professional association for the advancement of technology, NIH will conduct a workshop on Nanomedicine on Thursday and Friday. This will provide an opportunity for engineers and physical scientists to exhibit their cutting-edge technology, as well as to learn about possible biological applications for these technologies. Regulatory and intellectual property aspects of nanoresearch will also be addressed, in combination with presentations from some of the major industry efforts in the field.<br />
<br />
Events on Tuesday and Wednesday are open to the public and free of charge. Registration for the lab tours will open on April 1. The nanomedicine workshop on Thursday and Friday requires registration, which is located at <a href="https://roan2.wustl.edu/">https://roan2.wustl.edu/</a>. The full week’s agenda, as well as further information on NanoWeek 2009, can be found at <a href="http://www.capconcorp.com/nanoweek2009/">http://www.capconcorp.com/nanoweek2009/</a>. For more information on nanotechnology at the National Institutes of Health, see the Web site <a href="http://www.nibib.nih.gov/Research/NIHNano">http://www.nibib.nih.gov/Research/NIHNano</a>.<br />
<br />
The National Institute of Biomedical Imaging and Bioengineering (NIBIB), a component of the National Institutes of Health, U.S. Department of Health and Human Services, is dedicated to improving human health through the integration of the physical and biological sciences. The research agenda of the NIBIB will dramatically advance the Nation's health by improving the detection, management, understanding, and ultimately, the prevention of disease. Additional information and publications are available at <a href="http://www.nibib.nih.gov">www.nibib.nih.gov</a>.<br />
The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit <a href="http://www.nih.gov">www.nih.gov</a>.